Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination
CONCLUSION: Receipt of an mRNA COVID-19 vaccine during pregnancy was not associated with an increased risk of adverse pregnancy outcomes; this information will be helpful for patients and clinicians when considering COVID-19 vaccination in pregnancy.PMID:38626447 | DOI:10.1097/AOG.0000000000005583 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - April 16, 2024 Category: OBGYN Authors: Kimberly K Vesco Anna E Denoble Heather S Lipkind Elyse O Kharbanda Malini B DeSilva Matthew F Daley Darios Getahun Ousseny Zerbo Allison L Naleway Lisa Jackson Joshua T B Williams Thomas G Boyce Candace C Fuller Eric S Weintraub Gabriela Vazquez-Benitez Source Type: research
Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience
Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005585. Online ahead of print.ABSTRACTThere are limited data on the causative agents and characteristics of drug-induced liver injury in pregnant individuals. Data from patients with drug-induced liver injury enrolled in the ongoing multicenter Drug-Induced Liver Injury Network between 2004 and 2022 and occurring during pregnancy or 6 months postpartum were reviewed and compared with cases of drug-induced liver injury in nonpregnant women of childbearing age. Among 325 individuals of childbearing age in the Drug-Induced Liver Injury Network, 16 cases of drug-induced l...
Source: Obstetrics and Gynecology - April 16, 2024 Category: OBGYN Authors: Umair Masood Nicholas Venturini Paola Nicoletti Andrew Dellinger David Kleiner Herbert L Bonkovsky Huiman Barnhart Raj Vuppalanchi Simona Rossi Joseph A Odin Tatyana Kushner Source Type: research
Syphilis Treatment Among People Who Are Pregnant in Six U.S. States, 2018-2021
CONCLUSION: In this surveillance cohort, people without timely prenatal care had the highest risk for syphilis treatment inadequacy; however, almost a third of people who received timely prenatal care were not adequately treated. These findings underscore gaps in syphilis screening and treatment for pregnant people, especially those experiencing substance use and homelessness, and the need for systems-based interventions, such as treatment outside of traditional prenatal care settings.PMID:38626449 | DOI:10.1097/AOG.0000000000005586 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - April 16, 2024 Category: OBGYN Authors: Ayzsa Tannis Kathryn Miele Jeffrey M Carlson Kevin P O'Callaghan Kate R Woodworth Breanne Anderson Aisha Praag Kourtney Pulliam Nicole Coppola Teri' Willabus Deborah Mbotha Dejene Abetew Salvatore Currenti Nicole D Longcore Amanda Akosa Dana Meaney-Delman Source Type: research
Neurologic Emergencies in Pregnancy
Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005575. Online ahead of print.ABSTRACTNeurologic emergencies in pregnancy require prompt evaluation and early, focused intervention to improve neurologic outcomes for the affected person and to avoid further injury. Neurologic events in pregnancy, although rare, present a time of extreme risk of permanent injury for the person who is pregnant. Therefore, obstetric clinicians should be well versed in the risk factors for potential neurologic events and understand the symptoms and events that should prompt evaluation for a neurologic event. In addition, they should supp...
Source: Obstetrics and Gynecology - April 16, 2024 Category: OBGYN Authors: Shaun R Wesley G Edward Vates Loralei L Thornburg Source Type: research
National Postpartum Permanent Contraception Practices and Perceived Barriers
Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005584. Online ahead of print.ABSTRACTSingle institution-level studies have demonstrated low postpartum permanent contraception fulfillment rates after vaginal birth. To explore the national scope of the problem, we collected cross-sectional survey data from faculty at 109 U.S. academic medical centers to elicit perceptions about postpartum permanent contraception practices after vaginal birth, including barriers to and changes in practice after the Dobbs v Jackson Women's Health Organization decision, a decision that eliminated the U.S. federal protection of the righ...
Source: Obstetrics and Gynecology - April 16, 2024 Category: OBGYN Authors: Ellen Murphy Andrea Pelletier Kathryn Fay Deborah Bartz Source Type: research
Pathophysiology and Clinical Implications of Ovarian Endometriomas
Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005587. Online ahead of print.ABSTRACTOvarian endometriomas affect many patients with endometriosis and have significant effects on quality of life, fertility, and risk of malignancy. Endometriomas range from small (1-3 cm), densely fibrotic cysts to large (20 cm or greater) cysts with varying degrees of fibrosis. Endometriomas are hypothesized to form from endometriotic invasion or metaplasia of functional cysts or alternatively from ovarian surface endometriosis that bleeds into the ovarian cortex. Different mechanisms of endometrioma formation may help explain the ...
Source: Obstetrics and Gynecology - April 16, 2024 Category: OBGYN Authors: Farr R Nezhat Ann M Cathcart Ceana H Nezhat Camran R Nezhat Source Type: research
Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening
Obstet Gynecol. 2024 Apr 11. doi: 10.1097/AOG.0000000000005577. Online ahead of print.ABSTRACTNuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall, reported NT measurements decreased 74.3% from 2012 to 2022. A similar decline was noted among individuals with pregnancies at i...
Source: Obstetrics and Gynecology - April 11, 2024 Category: OBGYN Authors: Timothy Wen Loralei L Thornburg Mary E Norton Lawrence D Platt Lorraine Dugoff Ashley Hesson Jean L Spitz Gregory Toland Bryann Bromley Nuchal Translucency Quality Review Program of the Perinatal Quality Foundation Source Type: research
Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening
Obstet Gynecol. 2024 Apr 11. doi: 10.1097/AOG.0000000000005577. Online ahead of print.ABSTRACTNuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall, reported NT measurements decreased 74.3% from 2012 to 2022. A similar decline was noted among individuals with pregnancies at i...
Source: Obstetrics and Gynecology - April 11, 2024 Category: OBGYN Authors: Timothy Wen Loralei L Thornburg Mary E Norton Lawrence D Platt Lorraine Dugoff Ashley Hesson Jean L Spitz Gregory Toland Bryann Bromley Nuchal Translucency Quality Review Program of the Perinatal Quality Foundation Source Type: research
Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening
Obstet Gynecol. 2024 Apr 11. doi: 10.1097/AOG.0000000000005577. Online ahead of print.ABSTRACTNuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall, reported NT measurements decreased 74.3% from 2012 to 2022. A similar decline was noted among individuals with pregnancies at i...
Source: Obstetrics and Gynecology - April 11, 2024 Category: OBGYN Authors: Timothy Wen Loralei L Thornburg Mary E Norton Lawrence D Platt Lorraine Dugoff Ashley Hesson Jean L Spitz Gregory Toland Bryann Bromley Nuchal Translucency Quality Review Program of the Perinatal Quality Foundation Source Type: research
Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening
Obstet Gynecol. 2024 Apr 11. doi: 10.1097/AOG.0000000000005577. Online ahead of print.ABSTRACTNuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall, reported NT measurements decreased 74.3% from 2012 to 2022. A similar decline was noted among individuals with pregnancies at i...
Source: Obstetrics and Gynecology - April 11, 2024 Category: OBGYN Authors: Timothy Wen Loralei L Thornburg Mary E Norton Lawrence D Platt Lorraine Dugoff Ashley Hesson Jean L Spitz Gregory Toland Bryann Bromley Nuchal Translucency Quality Review Program of the Perinatal Quality Foundation Source Type: research
Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19): Autoimmune Follicle-Stimulating Hormone (FSH) and FSH Receptor Blockade
CONCLUSION: Auto-antibody production in response to COVID-19 before vaccination may be a rare cause of autoimmune poor ovarian response. Although vaccination is likely protective, further study will be required to evaluate the effect of vaccination and duration of autoimmune FSH or FSH receptor blockade.PMID:38574363 | DOI:10.1097/AOG.0000000000005574 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - April 4, 2024 Category: OBGYN Authors: Rachel Stern Moses Bibi Martin D Keltz Source Type: research
Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2-7 Years After Delivery
CONCLUSION: Individuals who experienced adverse pregnancy outcomes in their first birth were more likely to have a higher predicted 30-year risk of CVD measured at 2-7 years after delivery. The magnitude of risk was higher with a greater number of adverse pregnancy outcomes experienced.PMID:38574364 | DOI:10.1097/AOG.0000000000005569 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - April 4, 2024 Category: OBGYN Authors: Kartik K Venkatesh Sadiya S Khan Lynn M Yee Jiqiang Wu Rebecca McNeil Philip Greenland Judith H Chung Lisa D Levine Hyagriv N Simhan Janet Catov Christina Scifres Uma M Reddy Victoria L Pemberton George Saade C Noel Bairey Merz William A Grobman Nulliparo Source Type: research
High-Dose Buprenorphine Initiation in the Management of Opioid Use Disorder in Pregnancy
Obstet Gynecol. 2024 Apr 4. doi: 10.1097/AOG.0000000000005572. Online ahead of print.ABSTRACTBuprenorphine is commonly used as a treatment for opioid use disorder (OUD). Transition to buprenorphine traditionally has been done using a low-dose initiation regimen due to concerns surrounding precipitated withdrawal. There are increasing data supporting use of a high-dose initiation regimen in the nonpregnant population. This retrospective case series describes six individuals with OUD who underwent high-dose buprenorphine initiation in pregnancy. There were no instances of sedation, respiratory depression, supplemental oxygen...
Source: Obstetrics and Gynecology - April 4, 2024 Category: OBGYN Authors: Marissa Berry Miranda K Kiefer Katherine A Hinely Heather Bowden Audra Jordan Michael Vilensky Kara M Rood Source Type: research
Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer
CONCLUSION: Geographic disparities affect fertility-sparing treatment and ART rates among women with gynecologic or breast cancer. By acknowledging geographic factors, health care systems can ensure equitable access to fertility-preservation services.PMID:38574368 | DOI:10.1097/AOG.0000000000005570 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - April 4, 2024 Category: OBGYN Authors: Alexa Kanbergs Kirsten Jorgensen Nuria Agusti David Viveros-Carre ño Chi-Fang Wu Roni Nitecki John A Harris Terri Woodard Ryan Ramphul Jose Alejandro Rauh-Hain Source Type: research
Association Between Hypertensive Disorders of Pregnancy and Interval Neurocognitive Decline: An Analysis of the Hispanic Community Health Study/Study of Latinos
CONCLUSION: The presence of preeclampsia or eclampsia was not associated with interval neurocognitive decline. In this cohort of U.S. Hispanic/Latina individuals, gestational hypertension alone was associated with decreased processing speed and executive functioning later in life.PMID:38574370 | DOI:10.1097/AOG.0000000000005571 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - April 4, 2024 Category: OBGYN Authors: Tali Elfassy Shathiyah Kulandavelu Leah Dodds Robert A Mesa Tatjana Rundek Vera Sharashidze Michael Paidas Martha L Daviglus Michelle A Kominiarek Ariana M Stickel Krista M Perreira Marissa A Kobayashi Tanya P Garcia Carmen R Isasi Richard B Lipton Hector Source Type: research
